Related Experiment Video

Updated: Jun 21, 2026

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

The role of RAS modification for primary and secondary stroke prevention

Dan J Fintel1

  • 1Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. dfintel@northwestern.edu

Postgraduate Medicine
|July 31, 2009
PubMed

Insights

Choosing the right antihypertensive medication impacts stroke protection beyond just lowering blood pressure. Angiotensin receptor blockers offer comparable blood pressure control and stroke prevention with potentially better tolerability than ACE inhibitors.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Antihypertensive agents play a crucial role in cardiovascular health.
  • Stroke remains a leading cause of disability and mortality worldwide.
  • The choice of antihypertensive medication may influence stroke risk independently of blood pressure reduction.

Purpose of the Study:

  • To compare the efficacy of different antihypertensive agents in stroke protection.
  • To evaluate the tolerability profiles of angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin receptor blockers (ARBs).
  • To determine if ARBs offer advantages in stroke prevention compared to ACE-Is.

Main Methods:

  • Analysis of clinical trial data on antihypertensive agents.
  • Comparison of blood pressure control achieved by ACE-Is and ARBs.
  • Assessment of stroke incidence in patients treated with different antihypertensive classes.

Main Results:

  • Antihypertensive agent choice is a determinant of stroke protection, independent of blood pressure reduction.
  • Angiotensin-converting enzyme inhibitors (ACE-Is) provide effective blood pressure control and stroke protection.
  • Angiotensin receptor blockers (ARBs) demonstrate comparable blood pressure control to ACE-Is.
  • ARBs may offer superior tolerability compared to ACE-Is.

Conclusions:

  • Angiotensin receptor blockers (ARBs) provide effective blood pressure management and stroke prevention.
  • ARBs present a potentially more tolerable alternative to ACE-Is for patients requiring antihypertensive therapy.
  • The selection of antihypertensive medication, specifically ARBs, may enhance primary and secondary stroke prevention strategies.

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...